SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Marsili Daniel B (Last) (First) (Middle) COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE (Street) NEW YORK NY 10022 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/14/2005	3. Issuer Name and Ticker or Trading Symbol COLGATE PALMOLIVE CO [ CL ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP Global Human Resources	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,856	D
Common Stock	38	I	By Issuer's 401(k) Plan Trustee
Series B Convertible Preference Stock	611	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Convertible Preference Stock Units	(1)	(1)	Series B Convertible Preference Stock	12	0	D
Stock Option (Right to Buy)	09/09/2000(2)	09/09/2009	Common Stock	6,600	55.6563	D
Stock Option (Right to Buy)	10/17/2000(3)	09/05/2006	Common Stock	849	56.0938	D
Stock Option (Right to Buy)	10/17/2000(3)	09/11/2007	Common Stock	2,454	56.0938	D
Stock Option (Right to Buy)	10/17/2000(3)	09/10/2008	Common Stock	1,682	56.0938	D
Stock Option (Right to Buy)	04/26/2001(3)	09/11/2007	Common Stock	1,231	55.815	D
Stock Option (Right to Buy)	04/26/2001(3)	09/10/2008	Common Stock	1,685	55.815	D
Stock Option (Right to Buy)	04/26/2001(3)	09/06/2005	Common Stock	1,164	55.815	D
Stock Option (Right to Buy)	04/26/2001(3)	09/05/2006	Common Stock	2,508	55.815	D
Stock Option (Right to Buy)	09/14/2001(2)	09/14/2010	Common Stock	4,934	48.0625	D
Stock Option (Right to Buy)	09/15/2002(3)	09/10/2008	Common Stock	1,682	55.37	D
Stock Option (Right to Buy)	09/15/2002(3)	09/14/2010	Common Stock	2,270	55.37	D
Stock Option (Right to Buy)	09/15/2002(3)	09/05/2006	Common Stock	347	55.37	D
Stock Option (Right to Buy)	09/17/2002(2)	09/17/2011	Common Stock	9,000	56.675	D
Stock Option (Right to Buy)	09/12/2003(2)	09/12/2012	Common Stock	9,500	55.11	D
Stock Option (Right to Buy)	09/09/2004(2)	09/09/2009	Common Stock	16,000	55.6563	D
Stock Option (Right to Buy)	09/11/2004(2)	09/11/2009	Common Stock	9,450	56.565	D
Stock Option (Right to Buy)	09/09/2005(2)	09/09/2010	Common Stock	12,500	54.4	D

Explanation of Responses:

1. The reported preference stock units were acquired under the issuer's Supplemental Savings & Investment Plan and will be settled upon the the reporting person's retirement or other termination of service.

2. Option becomes exercisable in one-third increments on each anniversary date, with the first third becoming exercisable on the date shown in this column.

3. Option became 100% exercisable on the date shown in this column.

Remarks:

	Nina D. Gillman by power of attorney	07/22/2005
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

FORMS 3, 4 AND 5

I, Daniel B. Marsili, an officer of Colgate-Palmolive Company
(the "Company"), do hereby appoint Andrew D. Hendry, Nina D. Gillman,
Joyce M. McCarthy and J. Thomas Yust, severally, as my true and lawful
attorneys with the power to execute and file on my behalf and in my
place and stead,as I myself could do if I were personally present,
any Form 3, 4 or 5 to be filed by me pursuant to Section 16(a) of
the Securities Exchange Act of 1934 in connection with my ownership,
either directly or indirectly, or any change therein, of securities
of the Company.

This Power of Attorney shall remain in force and effect for
as long as I continue to be an officer of the Company or until earlier
revoked by me in writing and shall not otherwise be affected by my
subsequent disability or incompetence.

In witness whereof, I have signed this instrument
on July 20, 2005.



Signature:  /s/ Daniel B. Marsili
Print Name:    Daniel B. Marsili